Pilot study on silibinin as a possible therapeutic agent for mildly ill COVID-19 patients

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: a9b92990a7fe77518da5f6edee3a56d4199e614a
First added on: Jul 08, 2021